RenBio’s Dr. Rachel Liberatore took center stage at the AntibodyTherapeutics Xchange 2024 event held in Philadelphia this week. Dr. Liberatore led a captivating round table discussion on “Novel Delivery Modes for Biologics”.

The discussion was a dynamic exploration of strategies aimed at enhancing pharmacokinetics, tackling the challenges of cold chain requirements, and alleviating the burden associated with medical devices in the realm of biologic therapeutics. Dr. Liberatore’s expertise illuminated pathways for overcoming these hurdles, offering insights that promise to shape the future of biologics delivery.

For those who missed out, stay tuned for future opportunities to engage with RenBio experts!